ELMMB logo
Facebook logo Twitter logo
Drug Alerts and Withdrawals

Drug Alerts and Withdrawals

Drug Alerts and Withdrawals
 For more information about the MHRA click here 
 For MHRA Drug Safety Updates click here

When the MHRA, or occasionally another regulatory body in another country, such as the FDA, release advice, it is sometime necessary to produce additional local guidance.  This aims to be both clear and concise advice to healthcare professionals on the local action required to implement or respond to alerts issued by the MHRA or other bodies.  These memorandums are available below for reference, once they have been circulated to the relevant professionals in primary and secondary care:

MHRA News Stories.

 4th January 2022      MHRA Press Release Strong Steroid found in 'natural' skin cream. MHRA have issued a recall asking patients
                                     to return affected products.
11th Nov 2021           News Release Patient safety priority in recall of batches of cold and flu medicine with labelling error.
15th Sept 2021          MHRA Press Release The MHRA is advising anyone experiencing skin redness or burning sensations after
                                     they have stopped using these creams or ointments to seek advice from their health professional before
                                     using these products again.
 9th August 2021       MHRA Press Release MHRA recalls contaminated Irbesartan-batches as a precautionary measure. 
                                                                        Patients should not stop any treatments without consulting their doctor or pharmacist.
 8th July 2021             MHRA Press Release First progesterone-only contraceptive pills to be available to purchase from pharmacies      
 1st July 2021             Company led medicines recall: Morphine Syringe 50mg/50ml [unlicensed medicine] and Magnesium Sulphate
                                                                                         8mmol/20ml infusion [unlicensed medicine]
 17th June 2021         MHRA Press Release  MHRA recalls contaminated Irbesartan and Losartan batches as precautionary measure
 8th June 2021           MHRA Press Release  Over 3 million medicines and devices seized in UK as part of global crackdown
 28th May 2021         MHRA Press Release A personal trainer sentenced to 31 months in jail for selling and supplying unlicensed and                                                                                prescription medicines, together with Anabolic steroids, to the public.        
 4th May 2021           MHRA Press Release  MHRA announces appointment of Chief Safety Officer

MHRA Company-led Drug alerts

click here to access the most recent alerts

Items In This Category

application/pdfAtivan 4mg in 1mL sol for inj Class 4 Meds recall EL19A10Final.pdf (145KB)25/04/2019Download
application/pdfZoledronic_acid_solution_for_infusion_Drug_Alert.pdf (157KB)05/04/2019Download
 Ranbaxy (UK) Ltd a Sun Pharmaceutical Company, has informed us that some packs from the above batch contain a Patient Information Leaflet (PIL) for Temozolomide 180mg Capsules. 
application/pdfLosartan Potassium 50mg 100mg class 2 medicines recal Accord March 2019EL__19_A07_Final.pdf (144KB)25/03/2019Download
 losartan, accord, recall, drug, safety 
application/pdfOzurdex Intravitreal Implant in Applicator recall Allergan UK_Final_-DHPC_180319.pdf (69KB)18/03/2019Download
 Allergan Pharmaceuticals Ireland is further recalling batches due to the possibility that a single loose silicone particle of approximately 300 microns in diameter may become detached.  
application/pdfAtropine Sulfate 3mg per 10ml Soln for injection in pfs EL 19 A05 Final.pdf (151KB)18/02/2019Download
 Aguettant Limited has informed the MHRA that there is an error in the Patient Information Leaflet (PIL) for batches of the above product listed above. In Section 6 of the Leaflet included in these... 
application/pdfIrbesartan Class 2 medicines recall Actavis Group EL_19_A04-Final.pdf (163KB)14/02/2019Download
application/pdfIrbesartan 150mg Class 2 medicines recal EL__19_A02_Final.pdf (164KB)24/01/2019Download
 Macleods Pharma UK Limited is recalling the above batches from pharmacies as a precautionary measure due to possible contamination with N‑nitrosodiethylamine (NDEA). 
application/pdfIrbesartan hydrochlorothiazide Class 2 medicines recall MHRA.pdf (163KB)03/01/2019Download
 Class 2 Medicines Recall: Actavis Group PTC EHF – recall of batches of Irbesartan/Hydrochlorothiazide 300/12.5mg Film-coated Tablets and Irbesartan/Hydrochlorothiazide 150/12.5mg Film-coated Tablets 
application/pdfLidocaine teething products: talk to your pharmacist -patient-sheet.pdf (88KB)13/12/2018Download
 Key messages for parents and caregivers 
application/pdfValsartan Class 2 medicines recall 301118 MHRA.pdf (167KB)30/11/2018Download
 Teva is recalling the listed batches and Mylan is recalling all unexpired batches of the above products from pharmacies as a precautionary measure at a European level due to possible contamination... 
application/pdfOzurdex 700mcg intravitreal implant in applicator Class 2 medicines recall MHRA Final 0518.pdf (262KB)05/10/2018Download
 Allergan Pharmaceuticals Ireland is recalling some batches in the attached alert due to the possibility that a single loose silicone particle of approximately 300microns in diameter may become... 
application/pdfSodium Cromoglicate & Murine hayfever relief eye drops Class 3 medicines recall EL_18_A13-Final.pdf (132KB)31/07/2018Download
 FDC International Ltd is recalling the above batches due to the presence of a precipitate, which has been identified as Sodium Cromoglicate, in some bottles. 
Page: [1] [2] [3] [4] [5] [6] [7] [8] [9] [10]